Plan B Sales Continue In University Vending Machine, Unlikely To Spread
This article was originally published in The Tan Sheet
Executive Summary
FDA will not move to stop Plan B sales via vending machine at a college health clinic where the population is of a legal age to buy the product without a prescription. While the decision could open a door for a limited number of copycats, the landscape for nonprescription EC remains limited.
You may also be interested in...
In Brief
OTC HIV tests inch closer; FDA investigates Plan B vending machine; Crest toothpaste brightens in one use; L’Oreal sues J&J, Merck for sunscreen patent infringement; more News In Brief.
With Exclusivity For Single-Dose Plan B, Teva Stays One Step Up On Generics
Teva Pharmaceutical Industries likely will gain another three years of exclusivity in the branded nonprescription emergency contraceptive market with FDA's approval of a revised dosage of Plan B
People In Brief
Herbalife brings on Dentali as botanical sciences VP; NACDS expands Nicholson’s role; Innophos announces interim CFO; George Hamilton new face of Infusion Life Sciences; Aker BioMarine names sales VP; Atteryd to chair Food Supplements Europe.